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The complexes cis-PtLaCla (L = pyridine [l, 21, 
imidazole [3, 41 and N-methylimidazole [4-6] ) 
have been studied as potential anti-tumor drugs, and 
complexes of the related polydentate ligands 2,2’- 
bipyridyl and 2,2’:6’,2”-terpyridyl have been inves- 
tigated as intercalating agents for DNA [7]. We 
report here the synthesis of complexes of some 
related bidentate ligands containing pyridyl rings 
connected by a carbon atom, di-2-pyridylmethane 
(py&H2) and py$Et,, and containing both pyridyl 
and imidazolyl rings, (2,2’-pyridyl)imidazole (pyIm) 
and py-NMeIm. 
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The ligands pyzCHz and pyzCEtz were chosen 
because of their close relationship to pyridine and 
*Author to whom correspondence should be addressed. 
2,2’-bipyridyl; pyIm and py-NMeIm were chosen as 
these bidentates are expected to be coplanar with 
the PtCIZ group, in contrast to cis-PtLaCla (L = 
pyridine [8] , Him and NMeIm [6]). In addition 
pyIm has a proton that may become involved in 
hydrogen bonding, a factor which may be important 
in interaction of Pt(I1) complexes with DNA [9]. 
Preliminary screening of the complexes, together 
with cis-PtLaCla (L, = 2,2’-bipyridyl; L = NHa, 
pyridine), in vitro with L1210 mouse leukemia cells 
indicate that the complexes have I.D.sc values (con- 
centration of complex required to inhibit growth 
by 50%) higher than that of clinically useful [lo] 
cis-Pt(NHs)&lz, except for Pt(pyIm)Clz*HzO which 
has the same I.D.50 values as cis-Pt(NH&C12. 
Experimental 
Platinum sponge (Matthey Garrett, Sydney) was 
converted to K,PtCl, as described [ 111. The ligands 
py&Ha, pyIm, py-NMeIm, and pyzCEtz were prepar- 
ed previously [ 121. As all of the complexes were 
prepared in a similar manner the preparation of 
Pt(pyIm)Cl,*HaO is given as an example. Infrared 
spectra (4000-400 cm-‘) in Nujol and hexachloro- 
butadiene mulls, and far infrared spectra (600-200 
cm-‘) in Nujol mulls between polyethylene plates 
were recorded with a Perkin-Elmer 577 spectrometer; 
maximum errors are considered to be ca. 4 cm-‘. 
Conductivities were measured with a Philips PW 
9504/00 conductivity meter in dimethylformamide. 
Microanalyses were carried out by the Australian 
Microanalytical Service, Melbourne, and are record- 
ed in Table I. 
cis-Lkhloro[2(2’-pyn~dyl)imidazole]platinum(II) 
Monohydrate 
A solution of pyIm (0.3 g, 2.07 mmol) in 1 M 
hydrochloric acid was added to a filtered solution 
TABLE I. Analytical Data for the Complexes. 
Complex Found % Calcd. % 
C H Cl C H Ci 
Pt(pyzCHz)Cl, 30.2 2.5 16.4 30.3 2.3 16.3 
Pt(pyzCEta)Cla 36.2 3.7 14.2 36.6 3.7 14.4 
Pt(pyIm)Cla*HaO* 22.4 1.9 16.9 22.4 2.1 16.5 
Pt@y-NMeIm)C12 25.6 2.4 16.9 25.4 2.1 16.7 
‘Found: N, 9.6; Calcd. 9.8%. Drying at co. 110 “C for 2 hours over P20s in a vacuum gave Pt(pylmJ*ca. 0.5Hso. Found: C, 22.9; 
H, 1.9;Cl, 16.9;N, 10.1. Calcd.C, 22.9;H, 1.9;Cl, 16.9;N, 10.0%. 
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TABLE Il. Platinum-Chlorine Stretching Frequencies* and Conductance Data.b 
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Complex vas -1 
(cm ) 
“s Molar Conductance -1 
(cm ) (ohm-’ cm2 mol-’ ) 
Pt(w2CHz)Clz 342 s 329 s 1.0 
Pt(pyzCEtz)Clz 339 w 328 w 2.4 
Pt(pyIm)C12 l H2OC 3.43 w 329 s (sh,b) 6.7 
Pt(py-NMeIm)Clzd 342 m 330m 1.2 
aNujol mulls; s, strong; m, medium; w, weak; sh, shoulder; b, broad; v, very. bin dimethylformamide at lob3 M. ‘v(OH) 
3530 m(vb). dAn absorption at 356 m is assumed to be a ligand mode, shifted from 369 w in the free ligand. 
of K,PtCl, (0.08 g, 1.93 mmol) in water. The result- 
ing solution was stirred at ambient temperature for 
2 hr and a yellow powder collected by filtration and 
washed with water (0.6 g, 74%). For complexes of 
py2CH2 and py2CEt, the dihydrochloride salt of the 
ligand was dissolved in water and added to an 
aqueous solution of K,PtCl,. 
Procedure for Studies of Growth Inhibition 
Complexes were dissolved in dimethylsulphoxide 
at concentrations such that 0.005 ml of solution 
when added to 2 ml of culture medium gave the 
required drug concentration. Cultures were assessed 
using a Coulter counter 48 hrs after drug additions; 
0.005 ml of dimethylsulphoxide in 2 ml of medium 
had no effect on cell growth. 
Results and Discussion 
The complexes precipitated as yellow powders 
on reaction of the ligands with an acidic aqueous 
solution of K2PtC14. The complexes gave satisfactory 
microanalyses (Table I), and all of the complexes 
are insoluble in water but form non-conducting solu- 
tions in dimethylformamide (Table II), consistent 
with absence of ionic salts, e.g. Magnus type salts, 
as impurities. 
Infrared spectra indicate that pyridine ring vibra- 
tions are shifted in the usual manner observed on 
coordination [13, 141, e.g. the band at 405 cm-’ 
[ 141 for pyridine is raised on coordination [ 13, 141 
and similar shifts occur for the ligands studied here. 
Thus, bands at 403 w (py2CH2), 403 m (py2CEt2), 
400 m (pyIm), and 403 w cm-’ (py-NMeIm) occur 
at 453 m or 437 w(b), 456 w and/or 446 w, 430 w, 
and 431 w cm-‘, respectively, in the complexes. 
Platinum-chlorine stretching modes are readily 
identified in the range 343-328 cm-’ for the com- 
plexes by comparison with spectra of the ligands 
and cis-PtL2C12 (L = pyridine [15], imidazole [3], 
N-methylimidazole [6], and L2 = 2,2’-bipyridyl 
TABLE III. 50% Inhibitory Dose (I.D.& for cis-PtLsCl2 
Complexes.* 
L2 I.D.$ 
(mall-‘) 
PY~CH~ 1.0 x 1o-5 
pyzCEt2 3.5 x lo+ 
pyImC 1.0x 1o-6 
py-NMeIm d 
2,2’-bipyridyl 6.0 x lo+ 
(NH312 1.0x lod 
(pyridine), 7.0 x lo-+ 
‘Cultures of Ll210 mouse leukemia cells. bConcentration 
of complex, in dimethylsulphoxide, required to inhibit 
growth L1210 cells by 50%. ‘Monohydrate. dInsufii- 
ciently soluble to obtain concentrations >2 X 10e6 mol 
1-l. 
[16]) which have these modes in the range 345-320 
cm-’ (Table II). 
Preliminary screening of the complexes, including 
the 2,2’-bipyridyl complex and cis-PtL2Clz (L = NHa, 
pyridine), on cultures of L1210 mouse leukemia 
cells has been carried out (Table III) [ 171 . Results 
were obtained over a range of concentrations requir- 
ed to give lo-90% inhibition of growth, and the 
expected sigmoidal curves (percent growth vs. con- 
centration) were obtained. The complex cis-Pt(pyri- 
dine)2Clz gave an I.D.50 value higher than that of 
cis-Pt(NH3)2C12, consistent with earlier studies show- 
ing that this complex has lower activity than cis- 
Pt(NH3)2Cl2 against Ehrlich ascites and Sarcoma 180 
tumors in mice [ 1, 21. The complex Pt(pyIm)C12* 
Hz0 gave an I.D.se value similar to that of cis- 
Pt(NH3)2Cl2, and below values for the other com- 
plexes. These results suggest that further testing with 
tumor bearing animals is warranted for Pt(pyIm)C12* 
H20. 
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